Blood Plasma Derivatives Market Key Highlights:
- Market Size (2024): USD 35.21 Billion
- Projected Market Size (2034): USD 73.24 Billion
- CAGR (2023-2034): 7.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Blood Plasma Derivatives Market Definition
The Blood Plasma Derivatives Market is concerned with the production, supply and consumption of therapeutic blood products that are made using human blood plasma. Advances in plasma gathering procedures, separation methods, and medical uses have contributed to the growth of the market on a global scale. The global blood plasma derivatives market is on the rise due to the higher occurrence of hemophilia and health issues leading to increased consumption of medical services. In addition, government initiatives aimed at promoting plasma donation and its efficient utilization and rising patient education levels, as well as an increase in the range of blood plasma-based products provided approval, play a role in this market. This is also due to ongoing clinical research focused on Alternative medicines. Enhancement of plasma products through R&D, will present market growth opportunities. Some of the other factors contributing to the growth of the market include the presence of major manufacturing companies as well as the increasing healthcare expenditure. On the other hand, this growth of the market will be inhibited by adverse effects ranging from allergies, dizziness, increased heart rates, and breath shortages among others.
Blood Plasma Derivatives Market Segmentation:
By Type
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
By Application
- Hospital
- Retail Pharmacy
- Other
Blood Plasma Derivatives Market Companies:
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
